Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in KLH-WT1 (3)

Wednesday
Jun172009

NCT00923910

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Conditions: Acute Myelogenous (AML), Acute Lymphocytic (ALL), Chronic Myelogenous (CML), Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL)
Sponsors: National Cancer Institute (NCI)
Phase I, II

Date: DateJune 17, 2009 | Reference3 References
Categories CategoryCancer - Leukemia, CategoryCancer - Lymphoma
Tags , ,
Thursday
Sep082005

NCT00153608

WT1 Peptide Vaccination in Carcinomas

Conditions: WT1 Expressing Carcinoma
Sponsors: Charite University, Berlin, Germany
Phase II

Date: DateSeptember 8, 2005 | Reference1 Reference
Categories CategoryCancer - Leukemia, CategoryCancer - Tissue
Tags , ,
Thursday
Sep082005

NCT00153582

WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
Sponsors: Charite University, Berlin, Germany
Phase II

Date: DateSeptember 8, 2005 | Reference1 Reference
Categories CategoryCancer - Leukemia
Tags , ,